Pleural mesothelioma classification-update and challenges.
Dacic S.
Mod Pathol. 2022 Jan;35(Suppl 1):51-56. doi: 10.1038/s41379-021-00895-7. Epub 2021 Aug 31.
Malignant peritoneal mesothelioma.
Chun CP, Song LX, Zhang HP, Guo DD, Xu GX, Li Y, Xin X, Cao J, Li F.
Am J Med Sci. 2023 Jan;365(1):99-103. doi: 10.1016/j.amjms.2022.07.008. Epub 2022 Aug 6.
Pleural mesothelioma classification update.
Beasley MB, Galateau-Salle F, Dacic S.
Virchows Arch. 2021 Jan;478(1):59-72. doi: 10.1007/s00428-021-03031-7. Epub 2021 Jan 21.
Perspectives on the Treatment of Malignant Pleural Mesothelioma.
Janes SM, Alrifai D, Fennell DA.
N Engl J Med. 2021 Sep 23;385(13):1207-1218. doi: 10.1056/NEJMra1912719.
Malignant pleural mesothelioma: recent developments.
Sinn K, Mosleh B, Hoda MA.
Curr Opin Oncol. 2021 Jan;33(1):80-86. doi: 10.1097/CCO.0000000000000697.
Small Molecule Inhibitors of TEAD Auto-palmitoylation Selectively Inhibit Proliferation and Tumor Growth of NF2-deficient Mesothelioma.
Tang TT, Konradi AW, Feng Y, Peng X, Ma M, Li J, Yu FX, Guan KL, Post L.
Mol Cancer Ther. 2021 Jun;20(6):986-998. doi: 10.1158/1535-7163.MCT-20-0717. Epub 2021 Apr 13.
Mesothelioma: morphologic and immunohistochemical findings.
Churg A.
Pathologie (Heidelb). 2024 Sep;45(5):309-315. doi: 10.1007/s00292-024-01317-6. Epub 2024 Apr 3.
Updates on grading mesothelioma.
Schulte JJ, Husain AN.
Histopathology. 2024 Jan;84(1):153-162. doi: 10.1111/his.15065. Epub 2023 Oct 23.
Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
Ettinger DS, Wood DE, Stevenson J, Aisner DL, Akerley W, Bauman JR, Bharat A, Bruno DS, Chang JY, Chirieac LR, DeCamp M, Dilling TJ, Dowell J, Durm GA, Gettinger S, Grotz TE, Gubens MA, Hegde A, Lackner RP, Lanuti M, Lin J, Loo BW, Lovly CM, Maldonado F, Massarelli E, Morgensztern D, Mullikin TC, Ng T, Otterson GA, Patel SP, Patil T, Polanco PM, Riely GJ, Riess J, Shapiro TA, Singh AP, Tam A, Tanvetyanon T, Yanagawa J, Yang SC, Yau E, Gregory KM, Hughes M.
J Natl Compr Canc Netw. 2023 Sep;21(9):961-979. doi: 10.6004/jnccn.2023.0045.
Diagnostic mesothelioma biomarkers in effusion cytology.
Eccher A, Girolami I, Lucenteforte E, Troncone G, Scarpa A, Pantanowitz L.
Cancer Cytopathol. 2021 Jul;129(7):506-516. doi: 10.1002/cncy.22398. Epub 2021 Jan 19.
